Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma

Written By Ruchika Sharma3 July 2024 2:00 PM IST

Paris: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease

Written By Ruchika Sharma3 July 2024 11:20 AM IST

Indianapolis: Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved Alzheimer's treatment Kisunla...

AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial

Lynparza, Imfinzi combo recommended for nod in EU by CHMP for endometrial cancer: AstraZeneca

Written By Ruchika Sharma3 July 2024 10:00 AM IST

Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU)...

Marksans Pharma UK arm Relonchem gets marketing nod for high BP drug

Marksans Pharma arm bags UKMHRA marketing authorization for Rasagiline Relonchem, Olmesartan tablets

Written By Ruchika Sharma2 July 2024 5:13 PM IST

Mumbai: Marksans Pharma has announced that its wholly-owned subsidiary Relonchem Limited has received Marketing Authorization from UKMHRA...

Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID 19 prevention: AsraZeneca

Written By Ruchika Sharma1 July 2024 5:33 PM IST

Cambridge: AstraZeneca's Marketing Authorisation Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Perindopril case: Lupin to pay Euro 40 million fine to European Commission

Written By Ruchika Sharma1 July 2024 2:30 PM IST

The European Court of Justice has upheld the European Commission's decision to impose a Euro 40 million fine on Lupin Limited. This penalty arises...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Alembic Pharma bags USFDA tentative nod for Bosutinib Tablets to treat certain type of leukemia

Written By Ruchika Sharma1 July 2024 11:27 AM IST

Bosutinib tablets are indicated for the treatment of a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia.

Wockhardt plans to launch antibiotic Zaynich in early FY26

Written By Ruchika Sharma30 Jun 2024 2:00 PM IST

Mumbai: Wockhardt said that research and trials for the antibiotic Zaynich are advancing well, with plans for an early launch in FY26. Habil...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca Imfinzi fails in late-stage trial to treat type of lung cancer

Written By Ruchika Sharma30 Jun 2024 11:30 AM IST

Cambridge: AstraZeneca has announced the high-level results from the ADJUVANT BR.31 Phase III trial, sponsored by the Canadian Cancer Trials...

Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing Bengali

Over 36 percent of inspected drug-making units had to be shut: CDSCO chief

Written By Ruchika Sharma29 Jun 2024 2:30 PM IST

"The issues in the Indian pharma industry relate to "non-compliance which leads to quality issues," CDSCO Chief

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Orchid Pharma collaborates with Cipla to unveil antibiotic Cefepime-Enmetazobactam in India

Written By Ruchika Sharma29 Jun 2024 12:00 PM IST

New Delhi: Orchid Pharma Limited, based in Chennai, India, the only Indian pharmaceutical company to have ever invented a New Chemical Entity...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion

Written By Ruchika Sharma29 Jun 2024 10:00 AM IST

Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok